v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2022
Cash flows from operating activities:      
Net loss $ (11,645) $ (109,951) $ (10,256)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 13,816 18,050 21,278
Allowance for credit losses 2,508 2,763 432
Gain from business divestiture, see Note 7 (4,768) (5,764) 0
Stock-based compensation, excluding cash-settled awards 12,167 25,246 32,865
(Benefit) provision from deferred income taxes (3,196) 45 5,860
Non-cash gains (losses) on derivative financial instruments, net 330 426 (133)
Change in fair value of contingent consideration for business combinations 0 0 (134)
Other non-cash items, net (685) 681 766
Changes in operating assets and liabilities:      
Accounts receivable 12,436 59,186 (5,718)
Contract assets (7,340) 8,517 (7,115)
Inventories (960) (13,101) (363)
Prepaid expenses and other assets 5,307 (2,364) 8,465
Accounts payable and accrued expenses 4,332 (37,885) 4,885
Contract liabilities 13,897 18,000 (51,314)
Other liabilities (2,904) 174 1,761
Other, net 1,266 (1,010) 1,351
Net cash provided by (used in) operating activities 34,561 (36,987) 2,630
Cash flows from investing activities:      
Purchases of property and equipment (7,035) (8,274) (11,759)
Purchases of short-term investments (58,695) (55,150) (58,973)
Maturities and sales of short-term investments 75,906 48,765 52,978
Settlements of derivative financial instruments not designated as hedges (977) 201 (138)
Cash paid for capitalized software development costs (2,034) (3,408) (6,033)
Proceeds from Business divestiture, net of cost, see Note 7 4,975 37,635 0
Change in restricted bank time deposits, including long-term portion (2,782) 358 5,561
Other investing activities 0 0 513
Net cash provided by (used in) investing activities 9,358 20,127 (17,851)
Cash flows from financing activities:      
(Repayment) withdrawal from credit facility - presented as short term loan 0 (100,000) 100,000
Dividend paid to former parent 0 0 (35,000)
Dividends paid to noncontrolling interest (2,452) (2,934) (3,338)
Payments of contingent consideration for business combinations (financing portion) 0 0 (2,738)
Other financing activities 0 0 (181)
Net cash (used in) provided by financing activities (2,452) (102,934) 58,743
Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents (115) 617 41
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents 41,352 (119,176) 43,563
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period 39,044 158,220 114,657
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period 80,396 39,044 158,220
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents at end of period:      
Cash and cash equivalents 74,477 34,579 152,590
Restricted cash and cash equivalents included in restricted cash and cash equivalents and restricted bank time deposits 5,825 4,302 3,486
Restricted cash and cash equivalents included in other assets 94 163 2,144
Total cash, cash equivalents, restricted cash, and restricted cash equivalents $ 80,396 $ 39,044 $ 158,220